The emergence of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the weight loss community. This novel dual GIP and GLP-1 agonist medication appears to deliver notable improvements in body loss compared to current therapies. Preliminary clinical studies have indicat